Android
Nokia
Windows
Published on Fri, May 02, 2008 at 08:05 | Source : Moneycontrol.com
Updated at Mon, May 05, 2008 at 16:14
Marksans Pharma has declared its results for the quarter ended March 2008 (Q4). The company's net sales were at Rs 82.7 crore versus Rs 26.7 crore.
During the same quarter its net profit was at Rs 4.6 crore versus loss of Rs 7.8 crore.
PREVIOUS STORY
Accumulate Dishman Pharma; target of Rs 64: Dolat Capital
NEXT STORY
RIL's KG-D6 may see a further dip in output
CNBC-TV18 Exclusive Fin Min Sources Say SUUTI Plan Will Require Cabinet Approval
Feb 13 2012, 17:40
Bullish on gold, but see price correction ahead: Ventura
- in Commodities
Feb 13 2012, 17:39
Index funds best choice for long-term investment: Roongta
- in Investing
Feb 13 2012, 19:27 | Source: CNBC-TV18
'Diverse offerings in power helping to withstand headwinds'
Feb 13 2012, 13:33 | Source: CNBC-TV18
Vessel oversupply crashed rates, Baltic Dry Index: SCI
Subscribe to
Moneycontrol Newsletters
Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!